Kiran Sunitha S, Aithal Saraswathy, Belagavi Charalingappa S
Kiran Diagnostic Centre, Bengaluru, Karnataka, India.
Sri Krishna Specialist Care Center, Bengaluru, Karnataka, India.
J Lab Physicians. 2016 Jul-Dec;8(2):116-9. doi: 10.4103/0974-2727.180793.
Hemoglobin E (HbE) is estimated to affect at least one million people around the world. Carrier frequency of hemoglobin E/β-thalassemia (HbE/β-thalassemia) is highest in Southeast Asia, reaching as high as 60% in parts of Thailand, Laos, and Cambodia. In the Indian subcontinent, highest frequency is observed in The Northeast regions, but relatively rare in rest of the country. Increasing migration of population from highly affected areas is resulting in rising prevalence in The South and other parts of India. HbE/β-thalassemia is characterized by marked clinical diversity, phenotypic instability, and age-related changes in adaptation to anemia. This paper reports a case of HbE disease in an adult immigrant from Assam and documents the difficulties encountered in the definitive subtyping of HbE hemoglobinopathy. Distinguishing between homozygous HbE disease and HbE/β-thalassemia is a challenge to hematopathologist as both are clinically and hematologically similar.
据估计,全世界至少有100万人受血红蛋白E(HbE)影响。血红蛋白E/β地中海贫血(HbE/β-地中海贫血)的携带频率在东南亚最高,在泰国、老挝和柬埔寨的部分地区高达60%。在印度次大陆,东北部地区的频率最高,但在该国其他地区相对罕见。受影响严重地区人口迁移的增加导致印度南部和其他地区的患病率上升。HbE/β-地中海贫血的特点是临床差异显著、表型不稳定以及在适应贫血方面存在与年龄相关的变化。本文报告了一例来自阿萨姆邦的成年移民的HbE疾病病例,并记录了在HbE血红蛋白病明确亚型分类中遇到的困难。区分纯合子HbE疾病和HbE/β-地中海贫血对血液病理学家来说是一项挑战,因为两者在临床和血液学上都很相似。